A Coterra merger, $90+ oil, and a 59% EPS jump all converge on one date.
Year: 2026
The FDA ruling changed what PM can legally say about ZYN. Q2 earnings this morning will show...
Margins nearly doubled overnight. August 11 is when the math gets tested.
Auto onshoring, intermodal growth, and a ~9% revenue jump are all on the table.
Record client assets make this one of the most important brokerage reports of the quarter.
Net earnings up 60% and guidance raised this morning. The stock is still down ~22% this year.
A ~32% implied earnings move and a disputed “$20B backlog” are colliding with short sellers and a...
The stock is down sharply while subscription revenue grows at 22%. Something has to give.
The stock trades near a decade-low valuation while the business keeps generating billions in cash.
A Microsoft deal puts 3M's fiber optic technology at the center of AI infrastructure.
